Chen R. Semaglutide as a Novel Therapeutic Agent for Obesity and Type 2 Diabetes. TMBLS [Internet]. 2025 Oct. 11 [cited 2026 May 16];8:454-9. Available from: https://tmbls.org/index.php/ojs/article/view/73